Advancing Retinal Imaging for Cardiovascular Risk Assessment

• by Federico Bernardo Rossi, Antonio Gallo, Philippe Giral

• May 1, 2026

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

• by Kathryn Wighton

• May 14, 2026

• 6 min

Abnormal active myocardial relaxation by dipyridamole stress test in suspected early-stage heart failure with preserved ejection fraction: a retrospective exploratory analysis

• by Gabriella Locorotondo, Monica Filice, Francesca Augusta Gabrielli, Giacomo Moretti, Laura Manfredonia, Antonella Lombardo, Gaetano Antonio Lanza, Leonarda Galiuto

• May 28, 2026

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes

• by Xi He, Guanlian He, Liqin Qi, Yujie Chen, Zhaorong Lin, Wenjia Chen, Qintao Huang, Libin Liu, Zhaoyang Chen, Ruonan Gao

• May 15, 2026